SuspensionClinical Overview
Sucralfate Suspension (500mg/5ml) is an oral basic aluminum salt of sucrose octasulfate on the WHO Model List of Essential Medicines. Under acidic conditions (pH < 4), it polymerizes into an insoluble, polyanionic gel that adheres tenaciously to ulcerated mucosal tissue, protecting the ulcer crater from gastric acid, pepsin, and bile acids while stimulating endogenous prostaglandin synthesis and epidermal growth factor. Indicated for active duodenal ulcers, gastric ulcers, stress ulcer prophylaxis, and reflux esophagitis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Shake well before use. Take 10 mL (1 g) four times daily on an empty stomach: 1 hour before each meal and at bedtime. Continue for 4 to 8 weeks until complete ulcer healing is confirmed.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Constipation (occurs in 2-3% of patients), dry mouth, flatulence, nausea. Rare/Severe: Aluminum intoxication in dialysis patients, and gastric bezoar formation in patients with impaired gastric motility.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Decreases gastrointestinal absorption of fluoroquinolones, tetracyclines, digoxin, warfarin, and thyroxine; administer other medications at least 2 hours before or after sucralfate. Antacids should not be taken within 30 minutes of dosing.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Sucralfate 1g + Oxetacaine 10mg Suspension per 10ml
Sucralfate (1g) and Oxetacaine (10mg) Suspension (per 10ml) combines a cytoprotective mucosal adherent with a potent local anesthetic. In the presence of gastric acid, sucralfate polymerizes into a viscous paste that selectively binds to positively charged proteinaceous exudates on ulcer craters, forming a protective physical barrier against acid, pepsin, and bile salts. Oxetacaine provides surface anesthesia to gastric and esophageal mucosa even in strongly acidic conditions (pH 1-2), delivering rapid relief from intense burning pain. Indicated for active gastric ulcers, duodenal ulcers, severe erosive esophagitis, and acute gastritis with severe epigastric pain.
Lignocaine 4% w/w + Metronidazole 1% w/w + Sucralfate 7% w/w Cream
Lignocaine (4% w/w), Metronidazole (1% w/w), and Sucralfate (7% w/w) Cream is a specialized topical rectal formulation. Lignocaine produces rapid local analgesia by blocking voltage-gated sodium channels. Metronidazole provides topical antimicrobial activity against anaerobic rectal flora, reducing secondary infection and inflammation. Sucralfate forms an adhesive barrier over mucosal fissures and hemorrhoidal ulcers, accelerating re-epithelialization and tissue healing. Indicated for acute and chronic anal fissures, painful thrombosed hemorrhoids, and post-hemorrhoidectomy wound healing.